Cargando…

Correction: A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Chen, Yiran, Xie, Xiaoling, Wu, Anqin, Wang, Lei, Hu, Yuxing, Zhang, Honghao, Li, Yuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338601/ https://www.ncbi.nlm.nih.gov/pubmed/35906664 http://dx.doi.org/10.1186/s13046-022-02446-7

Ejemplares similares

A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia
por: Chen, Yiran, et al.
Publicado: (2018)

A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity
por: Xie, Xiaoling, et al.
Publicado: (2018)

Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities
por: Chen, Yiran, et al.
Publicado: (2020)

A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation
por: Li, Meifang, et al.
Publicado: (2019)

EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway
por: Huang, Rui, et al.
Publicado: (2018)

Synthetic molecular evolution of hybrid cell penetrating peptides
por: Kauffman, W. Berkeley, et al.
Publicado: (2018)

Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
por: Habault, Justine, et al.
Publicado: (2019)

Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity
por: Gronewold, Anja, et al.
Publicado: (2016)

Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia
por: Pan, Yunbao, et al.
Publicado: (2017)

BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
por: Sang, Xu, et al.
Publicado: (2022)

Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery
por: Zakeri-Milani, Parvin, et al.
Publicado: (2021)

Cell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy
por: Peña, Quim, et al.
Publicado: (2022)

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
por: Le Roy, Aude, et al.
Publicado: (2018)

BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
por: Ma, Li, et al.
Publicado: (2022)

A Mitochondria-Penetrating Peptide Exerts Potent Anti-Plasmodium Activity and Localizes at Parasites’ Mitochondria
por: Somsri, Sangdao, et al.
Publicado: (2021)

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
por: Tarantini, Francesco, et al.
Publicado: (2021)

The Anticancer Peptide TAT-RasGAP(317−326) Exerts Broad Antimicrobial Activity
por: Heulot, Mathieu, et al.
Publicado: (2017)

Pogostemon cablin extract as an anticancer agent on human acute myeloid leukemia
por: Chien, Ju‐Huei, et al.
Publicado: (2021)

Designing Potent Anticancer Peptides by Aurein 1.2 Key Residues Mutation and Catenate Cell-Penetrating Peptide
por: Salarpour Garnaie, Hamta, et al.
Publicado: (2023)

EPS Nuclear Physics Conference
por: De Witt-Huberts, P K A, et al.
Publicado: (1992)

Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia
por: Pan, Pan, et al.
Publicado: (2020)

The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide
por: Kim, Hong, et al.
Publicado: (2016)

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice
por: Xie, Xiaoling, et al.
Publicado: (2023)

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
por: Rosales, Mauro, et al.
Publicado: (2021)

Anticancer activity of Pupalia lappacea on chronic myeloid leukemia K562 cells
por: Ravi, Alvala, et al.
Publicado: (2012)

Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy
por: Carrà, Giovanna, et al.
Publicado: (2019)

The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
por: Lin, Chen, et al.
Publicado: (2013)

Enhanced Live‐Cell Delivery of Synthetic Proteins Assisted by Cell‐Penetrating Peptides Fused to DABCYL
por: Mandal, Shaswati, et al.
Publicado: (2021)

The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
por: Daghero, Hellen, et al.
Publicado: (2020)

Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability
por: Hu, Cuihua, et al.
Publicado: (2018)

Polypharmacological Cell-Penetrating Peptides from Venomous Marine Animals Based on Immunomodulating, Antimicrobial, and Anticancer Properties
por: Hemmati, Shiva, et al.
Publicado: (2022)

Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia
por: Wang, Hao, et al.
Publicado: (2023)

LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent
por: Camilio, Ketil André, et al.
Publicado: (2014)

Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it
por: Sulkshane, Prasad, et al.
Publicado: (2022)

Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013)

Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients
por: Giallongo, Cesarina, et al.
Publicado: (2014)

Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin
por: Han, Yixiang, et al.
Publicado: (2015)

Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia
por: Zhou, Fang-jiao, et al.
Publicado: (2021)

CpACpP: In Silico Cell-Penetrating Anticancer Peptide Prediction Using a Novel Bioinformatics Framework
por: Nasiri, Farid, et al.
Publicado: (2021)

Dynamic Length Changes of Telomeres and Their Nuclear Organization in Chronic Myeloid Leukemia
por: Samassekou, Oumar
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_14auagsqd13nlqglc7rfquuiqk